We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy


Anti-influenza Agents Inspired by Immunotherapy

Industry Insight   Jun 13, 2019

Anti-influenza Agents Inspired by Immunotherapy

Cloudbreak Antiviral Conjugates (AVCs) are not conventional antibody-drug conjugates (ADCs). Left: Oncology ADC using an antibody to deliver a toxic payload to a cancer cell. Right: Cloudbreak antiviral Fc conjugates (AVCs) use a novel antiviral drug (TM) to provide direct pathogen killing and to deliver an Fc antibody fragment domain (EM) to a pathogen for a focused immune response. Credit: Cidara Therapeutics

Michele Wilson PhD

Science Writer


Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free